Methods Sixty-one patients with NPC of T_ 1-4 N_ 0-1 M_0 were randomized into two groups: conventional fractionation radiotherapy (CFR) group and CFR+ ATO group.

• 方法将61例T1~4N0~1期鼻咽癌病人随机分入单纯放疗组和三氧化二砷放射增敏组,观察两组病人鼻咽肿瘤和颈部肿瘤消退情况及毒副作用。